Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension (DAYLIGHT)

This study has been completed.
Hartford Hospital
Abbott Northwestern Hospital
Information provided by (Responsible Party):
Thomas J. Wang, MD, Massachusetts General Hospital Identifier:
First received: November 11, 2010
Last updated: November 7, 2013
Last verified: November 2013